Literature DB >> 8886299

Effect of acute tryptophan depletion on behavioral, cardiovascular, and hormonal sensitivity to cholecystokinin-tetrapeptide challenge in healthy volunteers.

D Koszycki1, R M Zacharko, J M Le Melledo, S N Young, J Bradwejn.   

Abstract

Recent data suggest that serotonergic (5-HT) mechanisms may mediate the anxiogenic effects of cholecystokinin (CCK)-related peptides. Accordingly, we investigated the effect of lowering plasma tryptophan to the elicitation of behavioral, cardiovascular, and hormonal changes in healthy volunteers challenged with the tetrapeptide CCK agonist, CCK-4. Forty men without personal or family history of psychiatric disorders were randomly assigned to either a tryptophan-free amino acid mixture, which decreases central 5-HT concentrations, or a control mixture. Five hours after administration of the amino acid mixture, all subjects received a single intravenous injection of CCK-4. The main finding of the study was that acute depletion of tryptophan failed to modify the panicogenic and cardiovascular effects of CCK-4, although it did enhance CCK-4-mediated increases in ACTH/cortisol and prolactin secretion. While these findings suggest that at least part of the neuroendocrine action of CCK-4 is mediated through the 5-HT system, the locus of the 5-HT-CCK interaction and the specific 5-HT receptor subtype involved remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8886299     DOI: 10.1016/0006-3223(95)00479-3

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  11 in total

Review 1.  Revisiting the serotonin-aggression relation in humans: a meta-analysis.

Authors:  Aaron A Duke; Laurent Bègue; Rob Bell; Tory Eisenlohr-Moul
Journal:  Psychol Bull       Date:  2013-02-04       Impact factor: 17.737

2.  Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder.

Authors:  J Shlik; A Aluoja; V Vasar; E Vasar; T Podar; J Bradwejn
Journal:  J Psychiatry Neurosci       Date:  1997-11       Impact factor: 6.186

3.  Effects of a metabotropic glutamate(2/3) receptor agonist (LY544344/LY354740) on panic anxiety induced by cholecystokinin tetrapeptide in healthy humans: preliminary results.

Authors:  Michael Kellner; Christoph Muhtz; Kristina Stark; Alexander Yassouridis; Josef Arlt; Klaus Wiedemann
Journal:  Psychopharmacology (Berl)       Date:  2004-09-30       Impact factor: 4.530

4.  Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations.

Authors:  S Kõks; P T Männistö; M Bourin; J Shlik; V Vasar; E Vasar
Journal:  J Psychiatry Neurosci       Date:  2000-01       Impact factor: 6.186

5.  Functional neuroanatomy of CCK-4-induced panic attacks in healthy volunteers.

Authors:  Daniela Eser; Gregor Leicht; Jürgen Lutz; Stephan Wenninger; Valerie Kirsch; Cornelius Schüle; Susanne Karch; Thomas Baghai; Oliver Pogarell; Christine Born; Rainer Rupprecht; Christoph Mulert
Journal:  Hum Brain Mapp       Date:  2009-02       Impact factor: 5.038

6.  Tryptophan depletion does not modify response to CCK-4 challenge in patients with panic disorder after treatment with citalopram.

Authors:  Innar Tõru; Jakov Shlik; Eduard Maron; Veiko Vasar; David J Nutt
Journal:  Psychopharmacology (Berl)       Date:  2006-03-16       Impact factor: 4.530

7.  Impact of state and trait anxiety on the panic response to CCK-4.

Authors:  Daniela Eser; Stephan Wenninger; Thomas Baghai; Cornelius Schüle; Rainer Rupprecht
Journal:  J Neural Transm (Vienna)       Date:  2008-04-15       Impact factor: 3.575

8.  Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study.

Authors:  Daniela Eser; Cornelius Schüle; Thomas Baghai; Anette Floesser; Axel Krebs-Brown; Michaela Enunwa; Stephan de la Motte; Rolf Engel; Klaus Kucher; Rainer Rupprecht
Journal:  Psychopharmacology (Berl)       Date:  2007-02-23       Impact factor: 4.415

9.  Tryptophan research in panic disorder.

Authors:  Eduard Maron; Jakov Shlik; David J Nutt
Journal:  Int J Tryptophan Res       Date:  2008-08-14

10.  Effects of tryptophan depletion and tryptophan loading on the affective response to high-dose CO2 challenge in healthy volunteers.

Authors:  Alessandro Colasanti; Gabriel Esquivel; Erik den Boer; Annerieke Horlings; Abdul Dandachi; Jeff L Oostwegel; Eva L van Donkelaar; Eric J Griez; Koen Schruers
Journal:  Psychopharmacology (Berl)       Date:  2011-02-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.